Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan

IntroductionGuideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is unclear whether RAS inhibitors and beta-blockers can be...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kei Kawada, Tomoaki Ishida, Hitoshi Fukuda, Yuki Hyohdoh, Toru Kubo, Tomoyuki Hamada, Yuichi Baba, Toshinobu Hayashi, Fuka Aizawa, Kenta Yagi, Yuki Izawa-Ishizawa, Takahiro Niimura, Shinji Abe, Mitsuhiro Goda, Hiroaki Kitaoka, Keisuke Ishizawa
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-05-01
Serie:	Frontiers in Cardiovascular Medicine
Soggetti:	heart failure medications beta-blockers angiotensin-converting enzyme inhibitors angiotensin II receptor blockers heart failure with reduced left ventricular ejection fraction
Accesso online:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1377228/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!